5 Result(s)

Article

Transgenic mouse model of IgM⁺ lymphoproliferative disease mimicking Waldenström macroglobulinemia

Waldenström macroglobulinemia (WM) is a low-grade incurable immunoglobulin M⁺ (IgM⁺) lymphoplasmacytic lymphoma for which a genetically engineered mouse model of de novo tumor development is lacking. On the basis...

V S Tompkins, R Sompallae, T R Rosean, S Walsh, M Acevedo… in Blood Cancer Journal (2016)

Article

KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice

T R Rosean, C J Holman, V S Tompkins, X **g, M D Krasowski… in Blood Cancer Journal (2016)

Article

¹⁸F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib

¹⁸F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are useful imaging modalities for evaluating tumor progression and treatment responses in genetically engineered mouse m....

K Duncan, T R Rosean, V S Tompkins, A Olivier, R Sompallae, F Zhan… in Blood Cancer Journal (2013)